Releases

Vaccines to protect against coronavirus are being developed around the world. Development work has proceeded at a record pace and several marketing authorisation reviews are currently being conducted by the European Medicines Agency (EMA). The first vaccine is expected to receive marketing authorisation in Finland before the end of the year. 

The European Medicines Agency (EMA) has started the rolling review procedure on a fourth coronavirus vaccine candidate. The quality, safety and effectiveness of the vaccine are assessed with the same criteria as in the normal marketing authorisation process.